Deferasirox 125 mg, 250 mg, 500 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets for Oral Suspension
Available Strengths: 125 mg, 250 mg, 500 mg
Reference Brands: Exjade, Jadenu (film-coated)
Category: Anemia
Deferasirox treats transfusion-related iron overload. Available as Exjade and Jadenu in multiple strengths. Suitable for global pharma B2B supply.
Product Description:
Deferasirox is a leading oral iron chelation therapy used to manage chronic iron overload in patients receiving long-term blood transfusions, such as those with thalassemia or sickle cell disease. It is available as 125 mg, 250 mg, and 500 mg tablets for oral suspension, and 90 mg, 180 mg, and 360 mg film-coated tablets (Jadenu®). Trusted brands like Exjade and Jadenu are approved in the US and EU. Deferasirox is manufactured in GMP-certified facilities and is ideal for pharma B2B distribution, including hospitals, clinics, and global buyers. Contact us for bulk export and regulatory support.
Deferasirox — third party manufacturing & bulk supply
Deferasirox 125 mg, 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Deferasirox is supplied as Tablets for Oral Suspension — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Deferasirox listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Deferasirox →Frequently Asked Questions
Deferasirox is used for treating chronic iron overload in patients who require frequent blood transfusions, such as those with thalassemia or sickle cell disease.
Deferasirox is made from the active ingredient deferasirox along with inactive excipients depending on whether it is a dispersible tablet or film-coated tablet.
The trade names are Exjade and Jadenu.
Deferasirox (Exjade and Jadenu) is manufactured by Novartis Pharmaceuticals.
The generic name is deferasirox.
The brand names are Exjade and Jadenu.
Deferasirox is manufactured by Novartis in approved facilities located in the USA and Europe.
Related Products
Iron(Iii)-Isomaltoside Injection
Strength:
100mg/ml
Form: Injection
Reference Brands: Monofer,, Diafer, Monoferric
View Details
Deferoxamine
Strength:
500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details
Polysaccharide-Iron Complex
Strength:
150 mg
Form: Capsules
Reference Brands: Niferex, Ferrex 150, Ferrousal
View Details
Eltrombopag Cholin 50 Mg Tablet
Strength:
12.5 mg, 25 mg, 50 mg, and 75 mg
Form: Tablets / Oral suspension
Reference Brands: Promacta (USA), Revolade (EU)
View Details
Mitapivat Sulfate
Strength:
5 mg, 20 mg, 50 mg
Form: Tablets
Reference Brands: Pyrukynd (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
